These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables. John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, Klodell CT, Milano CA, Rogers J, Farrar DJ, Frazier OH. J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659 [Abstract] [Full Text] [Related]
4. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). Starling RC, Naka Y, Boyle AJ, Gonzalez-Stawinski G, John R, Jorde U, Russell SD, Conte JV, Aaronson KD, McGee EC, Cotts WG, DeNofrio D, Pham DT, Farrar DJ, Pagani FD. J Am Coll Cardiol; 2011 May 10; 57(19):1890-8. PubMed ID: 21545946 [Abstract] [Full Text] [Related]
5. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. Holman WL, Kormos RL, Naftel DC, Miller MA, Pagani FD, Blume E, Cleeton T, Koenig SC, Edwards L, Kirklin JK. J Heart Lung Transplant; 2009 Jan 10; 28(1):44-50. PubMed ID: 19134530 [Abstract] [Full Text] [Related]
6. Incidence and clinical significance of late right heart failure during continuous-flow left ventricular assist device support. Takeda K, Takayama H, Colombo PC, Yuzefpolskaya M, Fukuhara S, Han J, Kurlansky P, Mancini DM, Naka Y. J Heart Lung Transplant; 2015 Aug 10; 34(8):1024-32. PubMed ID: 25935438 [Abstract] [Full Text] [Related]
7. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database. Cleveland JC, Naftel DC, Reece TB, Murray M, Antaki J, Pagani FD, Kirklin JK. J Heart Lung Transplant; 2011 Aug 10; 30(8):862-9. PubMed ID: 21621423 [Abstract] [Full Text] [Related]
9. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, Massey T, Milano CA, Moazami N, Sundareswaran KS, Farrar DJ, HeartMate II Clinical Investigators. J Thorac Cardiovasc Surg; 2010 May 10; 139(5):1316-24. PubMed ID: 20132950 [Abstract] [Full Text] [Related]
13. Late right heart failure during support with continuous-flow left ventricular assist devices adversely affects post-transplant outcome. Takeda K, Takayama H, Colombo PC, Jorde UP, Yuzefpolskaya M, Fukuhara S, Mancini DM, Naka Y. J Heart Lung Transplant; 2015 May 24; 34(5):667-74. PubMed ID: 25577566 [Abstract] [Full Text] [Related]
14. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices? Sabashnikov A, Popov AF, Bowles CT, Mohite PN, Weymann A, Hards R, Hedger M, Wittwer T, Wippermann J, Wahlers T, Schoendube FA, Simon AR. J Thorac Cardiovasc Surg; 2014 Sep 24; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605 [Abstract] [Full Text] [Related]
15. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW. Circulation; 2007 Jul 31; 116(5):497-505. PubMed ID: 17638928 [Abstract] [Full Text] [Related]
16. Association of pre-operative interleukin-6 levels with Interagency Registry for Mechanically Assisted Circulatory Support profiles and intensive care unit stay in left ventricular assist device patients. Caruso R, Verde A, Cabiati M, Milazzo F, Boroni C, Del Ry S, Parolini M, Vittori C, Paino R, Martinelli L, Giannessi D, Frigerio M, Parodi O. J Heart Lung Transplant; 2012 Jun 31; 31(6):625-33. PubMed ID: 22386451 [Abstract] [Full Text] [Related]
17. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L. Ann Thorac Surg; 2008 Oct 31; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167 [Abstract] [Full Text] [Related]
18. Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation. Nativi JN, Drakos SG, Kucheryavaya AY, Edwards LB, Selzman CH, Taylor DO, Hertz MI, Kfoury AG, Stehlik J. J Heart Lung Transplant; 2011 Aug 31; 30(8):854-61. PubMed ID: 21571550 [Abstract] [Full Text] [Related]
19. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients. Kamdar F, Boyle A, Liao K, Colvin-adams M, Joyce L, John R. J Heart Lung Transplant; 2009 Apr 31; 28(4):352-9. PubMed ID: 19332262 [Abstract] [Full Text] [Related]
20. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices. Kamdar F, John R, Eckman P, Colvin-Adams M, Shumway SJ, Liao K. J Thorac Cardiovasc Surg; 2013 Feb 31; 145(2):575-81. PubMed ID: 23321132 [Abstract] [Full Text] [Related] Page: [Next] [New Search]